<?xml version="1.0" encoding="UTF-8"?>
<ref id="B34-vaccines-07-00074">
 <label>34.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chaillon</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Braibant</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hu√©</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bencharif</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Enard</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Moreau</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Samri</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Agut</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Barin</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Human Immunodeficiency Virus Type-1 (HIV-1) Continues to Evolve in Presence of Broadly Neutralizing Antibodies More than Ten Years after Infection</article-title>
  <source>PLoS ONE</source>
  <year>2012</year>
  <volume>7</volume>
  <elocation-id>e44163</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0044163</pub-id>
  <pub-id pub-id-type="pmid">22957000</pub-id>
 </element-citation>
</ref>
